Streetbeat News

Analyst Ratings

BCC

BMO Capital analyst Ketan Mamtora maintains a Market Perform rating on Boise Cascade (NYSE:BCC) and lowers the price target from $115 to $112.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 5:42 pm

DOCN

Goldman Sachs has upgraded its rating for DigitalOcean Holdings Inc (NYSE:DOCN) from Sell to Buy, maintaining a price target of $33. The stock has underperformed this year due to a normalization in cloud optimization spending and management transition. However, Goldman Sachs believes that as the macro environment stabilizes, the structural improvements made by DigitalOcean will drive better revenue growth and continued FCF margin expansion.

Portfolio Pulse from Priya Nigam

November 07, 2023 | 5:41 pm

AMK

BMO Capital analyst James Fotheringham has maintained a 'Market Perform' rating on AssetMark Financial Holdings (NYSE:AMK) and lowered the price target from $33 to $32.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 5:40 pm

ALB

BMO Capital analyst Joel Jackson has maintained an 'Outperform' rating on Albemarle (NYSE:ALB), but lowered the price target from $265 to $180.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 5:36 pm

ADTN

ADTRAN reported mixed Q3 results and issued Q4 revenue guidance below estimates. Rosenblatt downgraded the stock from Buy to Neutral and lowered its price target from $11 to $7.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 5:32 pm

NXPI

NXP Semiconductors NV (NASDAQ:NXPI) shares rose after the company reported its Q3 results. Despite a 1% sequential decline in revenues in Q4 guidance, analysts from KeyBanc Capital Markets, Mizuho Securities, BofA Securities, Oppenheimer, and Stifel are not disappointed. They highlighted the company's better-than-expected Q3 earnings, efficient cost management, and performance in mobile, industrial, and auto segments. However, they also noted potential risks such as slowing auto/industrials, supply/pricing risk, and increasing inventories.

Portfolio Pulse from Priya Nigam

November 07, 2023 | 5:31 pm

MGNX

MacroGenics reported Q3 financial results, leading to an upgrade of its stock from Neutral to Buy by Guggenheim, with a price target of $12. This has resulted in MacroGenics shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 5:29 pm

MNDY

Shares of Monday.Com are trading higher following an upgrade from DA Davidson, which changed its rating from Neutral to Buy.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 5:27 pm

VRTX

BMO Capital analyst Evan Seigerman maintains an Outperform rating on Vertex Pharmaceuticals (NASDAQ:VRTX) and raises the price target from $389 to $415.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 5:25 pm

EH

EHang Holdings Limited (NASDAQ:EH) has responded to a report by short seller Hindenburg Research, stating that it contains untrue statements and misinterpretations about the company's business operations and financial conditions. EHang denies allegations that it misled investors about its order pipeline and sales, and plans to take actions to protect its and its shareholders' interests.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 5:21 pm